NVIDIA
NVDA
Tesla
TSLA
Taiwan Semiconductor
TSM
4
Palantir
PLTR
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
ALLR Allarity Therapeutics
- 0.8658
- -0.0143-1.62%
Trading Mar 4 13:37 ET
3.84MMarket Cap-0.12P/E (TTM)
0.9477High0.8300Low2.31MVolume0.8801Open0.8801Pre Close2.01MTurnover52.10%Turnover Ratio0.00P/E (Static)4.43MShares250.800052wk High0.30P/B3.84MFloat Cap0.677552wk Low--Dividend TTM4.43MShs Float15288000.0000Historical High--Div YieldTTM13.37%Amplitude0.6775Historical Low0.8690Avg Price1Lot Size
About Allarity Therapeutics Company
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA.
Company Profile
SymbolALLR
Company NameAllarity Therapeutics
Listing DateDec 21, 2021
Founded2021
CEOMr. Thomas H. Jensen
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address24 School Street,2nd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02108
Phone1-401-426-4664
Websitehttp://www.allarity.com
Company Executives
- Name
- Position
- Salary
- Thomas H. Jensen
- Chief Executive Officer and Director
- 24.72K
- Alexander Epshinsky
- Chief Financial Officer
- --
- Dr. Steen Knudsen, PhD
- Chief Scientific Officer
- 266.22K
- Dr. Jeremy Graff, PhD
- President and Chief Development Officer
- --
- Joan Y. Brown
- Director, Financial Reporting and Principal Accounting Officer
- 250.00K
- Gerald W. McLaughlin
- Chairman of the Board
- 107.38K
- Joseph W. Vazzano, C.P.A.
- Independent Director
- 29.17K
- Dr. Laura E. Benjamin, PhD
- Independent Director
- 27.71K